These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 7936100)
1. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat. Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100 [TBL] [Abstract][Full Text] [Related]
2. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists. Giorgi O; Biggio G Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234 [TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Saller CF; Kreamer LD; Adamovage LA; Salama AI Life Sci; 1989; 45(10):917-29. PubMed ID: 2529407 [TBL] [Abstract][Full Text] [Related]
4. EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors. Nowak G; Arnt J; Hyttel J Eur J Pharmacol; 1988 Aug; 153(2-3):309-11. PubMed ID: 3053212 [TBL] [Abstract][Full Text] [Related]
5. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine. Burger LY; Martin-Iverson MT Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985 [TBL] [Abstract][Full Text] [Related]
6. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism. Abercrombie ED; DeBoer P J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding. Engber TM; Marin C; Susel Z; Chase TN Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970 [TBL] [Abstract][Full Text] [Related]
8. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ. Crawford CA; Rowlett JK; McDougall SA; Bardo MT Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063 [TBL] [Abstract][Full Text] [Related]
9. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat. Wachtel SR; Brooderson RJ; White FJ Psychopharmacology (Berl); 1992; 109(1-2):41-8. PubMed ID: 1365670 [TBL] [Abstract][Full Text] [Related]
10. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ; Marshall JF Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762 [TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion. Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981 [TBL] [Abstract][Full Text] [Related]
12. Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset. Gnanalingham KK; Erol DD; Hunter AJ; Smith LA; Jenner P; Marsden CD Psychopharmacology (Berl); 1995 Feb; 117(3):275-86. PubMed ID: 7770603 [TBL] [Abstract][Full Text] [Related]
13. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ. Neisewander JL; Ong A; McGonigle P Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Cox RF; Waszczak BL Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308 [TBL] [Abstract][Full Text] [Related]
15. Relative roles of ventral striatal D1 and D2 dopamine receptors in responding with conditioned reinforcement. Wolterink G; Phillips G; Cador M; Donselaar-Wolterink I; Robbins TW; Everitt BJ Psychopharmacology (Berl); 1993; 110(3):355-64. PubMed ID: 7831431 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics. Meller E; Bohmaker K; Goldstein M; Friedhoff AJ J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276 [TBL] [Abstract][Full Text] [Related]
17. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum. Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398 [TBL] [Abstract][Full Text] [Related]
18. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions. Giorgi O; Biggio G Pharmacol Biochem Behav; 1990 Apr; 35(4):877-84. PubMed ID: 1971721 [TBL] [Abstract][Full Text] [Related]
19. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone. Protais P; Lesourd M; Comoy E Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353 [TBL] [Abstract][Full Text] [Related]
20. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study. Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]